Flusilazole

• Identification
• Experimental evidence
• Physicochemical properties
• ADMET properties
• Descriptors
• Chemical-gene interaction
• Chemical-phenotype interaction
• Chemical-disease association
• ToxCast endpoints
• Associated AOPs
• Presence in consumer products
• Presence in chemical regulation or guideline
• Presence in human biospecimen

Literature identifier	Study type	Test dosage	Effective dosage	Endocrine-mediated endpoints	Systems-level perturbations
PMID:31610510	IVTH	0.00000313 M	0.00000313 M	Decrease in cortisol levels	Neurological endocrine-mediated perturbations
	IVTH	0.00000625 M	0.00000625 M	Decreased Dehydroepiandrosterone (DHEA) levels	Metabolic endocrine-mediated perturbations
	IVTH	0.00000625 M	0.00000625 M	Decreased pregnenolone levels	Reproductive endocrine-mediated perturbations
	IVTH	0.0000125 M	0.0000125 M	Affects steroid metabolism	Metabolic endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations
	IVTH	0.00000625 M	0.00000625 M	Decreased estrone levels	Reproductive endocrine-mediated perturbations
	IVTH	0.0000125 M	0.0000125 M	Decrease in cortisol levels	Neurological endocrine-mediated perturbations
	IVTH	0.0000125 M	0.0000125 M	Decreased androstenedione levels	Reproductive endocrine-mediated perturbations
	IVTH	0.00000313 M	0.00000313 M	Increased progesterone levels	Reproductive endocrine-mediated perturbations
	IVTH	0.00000178 M	0.00000178 M	Decrease in cortisol levels	Neurological endocrine-mediated perturbations
	IVTH	0.00000178 M	0.00000178 M	Affects steroid metabolism	Metabolic endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations
	IVTH	0.00000313 M	0.00000313 M	Decrease in corticosterone levels	Neurological endocrine-mediated perturbations
	IVTH	0.00000625 M	0.00000625 M	Decrease in corticosterone levels	Neurological endocrine-mediated perturbations
	IVTH	0.0000125 M	0.0000125 M	Decreased estrone levels	Reproductive endocrine-mediated perturbations
	IVR	15 mg/kg/day	15 mg/kg/day	Increased androstenedione levels	Reproductive endocrine-mediated perturbations
	IVTH	0.00000313 M	0.00000313 M	Decreased estradiol levels	Reproductive endocrine-mediated perturbations
	IVTH	0.0000125 M	0.0000125 M	Decreased pregnenolone levels	Reproductive endocrine-mediated perturbations
	IVTH	0.000025 M	0.000025 M	Decrease in cortisol levels	Neurological endocrine-mediated perturbations
	IVTH	0.000025 M	0.000025 M	Decreased 17-OH-progesterone levels	Reproductive endocrine-mediated perturbations
	IVTH	0.00000625 M	0.00000625 M	Increased progesterone levels	Reproductive endocrine-mediated perturbations
	IVTH	0.00000078 M	0.00000078 M	Decrease in corticosterone levels	Neurological endocrine-mediated perturbations
	IVTH	0.00000078 M	0.00000078 M	Affects steroid metabolism	Metabolic endocrine-m
	IVTH	0.00000078 M	0.00000078 M	Decrease in cortisol levels
	IVTH	0.000025 M	0.000025 M	Decrease in corticosterone levels
	IVTH	0.000025 M	0.000025 M	Decreased androstenedione levels
	IVTH	0.000025 M	0.000025 M	Decreased testosterone levels
	IVTH	0.000025 M	0.000025 M	Decreased pregnenolone levels
	IVTH	0.000025 M	0.000025 M	Decreased estrone levels
	IVTH	0.00000625 M	0.00000625 M	Decreased testosterone levels
	IVTH	0.00005 M	0.00005 M	Increased progesterone levels
	IVTH	0.000025 M	0.000025 M	Decreased Dehydroepiandrosterone (DHEA) levels
	IVTH	0.000025 M	0.000025 M	Decreased estradiol levels
	IVTH	0.000025 M	0.000025 M	Increased progesterone levels
	IVTH	0.000025 M	0.000025 M	Affects steroid metabolism
	IVTH	0.00000625 M	0.00000625 M	Decrease in
	IVTH	0.00000313 M	0.00000313 M
	IVR	45 mg/kg/day	45 mg/kg/day
	IVTH	0.00000625 M	0.00000625 M
	IVTH	0.00000313 M	0.00000313 M
	IVTH	0.00000625 M	0.00000625 M
	IVTH	0.0000125 M	0.0000125 M
	IVTH	0.0000125 M	0.0000125 M
	IVTH	0.00000313 M	0.00000313 M
	IVTH	0.0000125 M	0.0000125 M
	IVTH	0.0000125 M	0.0000125 M
	IVTH	0.00000625 M	0.00000625 M
	IVR	45 mg/kg/day	45 mg/kg/day
	IVTH	0.00000178 M	0.00000178 M
	IVTH	0.0000125 M	0.0000125 M
PMID:33032228	IVR	45 mg/kg/day	45 mg/kg/day	Affects testicular development	Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations

---

DISCLAIMER

We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.